ExodusPoint Capital Management, LP

Position in LNTH — Lantheus Holdings, Inc.

CIK 1736225 NEW YORK, NY

Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$16,408,023

+$13,721,994 QoQ

Shares Held

216,322

+401.3% QoQ

Ownership

0.332%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $58,166,201 across 15 Drug Manufacturers - Specialty & Generic names. LNTH ranks #1 (28.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LNTH	Lantheus Holdings, Inc. This page	216,322	$16,408,023
2	ELAN	Elanco Animal Health Inc	570,032	$13,640,865
3	SUPN	Supernus Pharmaceuticals, Inc.	202,116	$10,447,376
4	ALKS	Alkermes plc.	204,324	$7,224,896
5	KNSA	Kiniksa Pharmaceuticals International, plc	52,303	$2,518,389
6	PRGO	PERRIGO Co plc	190,050	$2,041,137
7	AMRX	Amneal Pharmaceuticals, Inc.	161,700	$2,009,931
8	BCRX	Biocryst Pharmaceuticals Inc	190,058	$1,809,352

All Filings in LNTH

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$16,408,023	216,322	+401.3%	Shares	Sole	2026-05-14
2024-03-31	$2,686,029	43,156	+170.6%	Shares	Sole	2024-05-14
2023-12-31	$988,962	15,951	-93.1%	Shares	Sole	2024-02-14
2023-09-30	$15,955,039	229,635	+64.3%	Shares	Sole	2023-11-13
2023-06-30	$11,728,323	139,756	+229.9%	Shares	Other	2023-08-11
2023-03-31	$3,497,489	42,363	-40.3%	Shares	Other	2023-05-11
2022-12-31	$3,615,102	70,940	+190.9%	Shares	Other	2023-02-13
2022-09-30	$1,715,067	24,386	—	Shares	Other	2022-11-10
No filing history on record for this holder in this stock.